Valuation: CEREP

Market Cap 82.22M 93.8M 76M 69.9M 132M 9.05B 134M 909M 356M 4.43B 352M 345M 15.25B P/E 2024 *
-
P/E 2025 -
Enterprise Value 61.18M 69.8M 56.55M 52.01M 98.14M 6.73B 99.71M 676M 265M 3.29B 262M 256M 11.35B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%-3.54%+0.04%+14.44% 48.71B
+1.24%-1.16%+375.86%+582.95% 38.35B
+2.63%+4.24%+9.47%+61.81% 34.53B
-0.88%-2.32%+27.71%-11.06% 34.03B
-1.82%-1.43%+0.52%+31.85% 26.77B
+1.84%-4.33% - - 15.64B
+1.33%-0.12%+73.37%+118.33% 15.08B
-2.19%+0.72%+12.86%+13.75% 14.18B
-0.18%-1.61%+18.36%-32.80% 12.73B
Average +0.23%-1.12%+64.77%+97.41% 26.67B
Weighted average by Cap. +0.31%-1.44%+76.76%+121.37%

Financials

2024 2025
Net sales 40.49M 46.19M 37.42M 34.42M 64.94M 4.45B 65.99M 447M 175M 2.18B 173M 170M 7.51B 41.1M 46.89M 37.99M 34.94M 65.92M 4.52B 66.98M 454M 178M 2.21B 176M 172M 7.62B
Net income 7.15M 8.16M 6.61M 6.08M 11.48M 787M 11.66M 79.08M 31M 385M 30.65M 29.98M 1.33B 4.78M 5.46M 4.42M 4.07M 7.67M 526M 7.79M 52.86M 20.72M 257M 20.49M 20.04M 887M
Net Debt -17.25M -19.68M -15.95M -14.67M -27.67M -1.9B -28.12M -191M -74.75M -929M -73.91M -72.3M -3.2B -21.03M -24M -19.44M -17.88M -33.74M -2.31B -34.28M -232M -91.14M -1.13B -90.12M -88.15M -3.9B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-